Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-21-008618
Filing Date
2021-04-13
Accepted
2021-04-13 12:17:38
Documents
3
Period of Report
2021-04-13

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 276855
2 proxy_001.jpg GRAPHIC 109868
3 proxy_002.jpg GRAPHIC 92593
  Complete submission text file 0001493152-21-008618.txt   557019
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38286 | Film No.: 21822535
SIC: 3674 Semiconductors & Related Devices